These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26893133)

  • 1. Metabolism of murine TH 17 cells: Impact on cell fate and function.
    Wang R; Solt LA
    Eur J Immunol; 2016 Apr; 46(4):807-16. PubMed ID: 26893133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells.
    Shi LZ; Wang R; Huang G; Vogel P; Neale G; Green DR; Chi H
    J Exp Med; 2011 Jul; 208(7):1367-76. PubMed ID: 21708926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic intermittent hypoxia promotes the development of experimental non-alcoholic steatohepatitis by modulating Treg/Th17 differentiation.
    Liu J; Li W; Zhu W; He W; Zhao H; Xiang Y; Liu C; Wu W
    Acta Biochim Biophys Sin (Shanghai); 2018 Dec; 50(12):1200-1210. PubMed ID: 30379980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation.
    Jang SW; Hwang SS; Kim HS; Lee KO; Kim MK; Lee W; Kim K; Lee GR
    Exp Mol Med; 2017 Sep; 49(9):e375. PubMed ID: 28883547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.
    Berod L; Friedrich C; Nandan A; Freitag J; Hagemann S; Harmrolfs K; Sandouk A; Hesse C; Castro CN; Bähre H; Tschirner SK; Gorinski N; Gohmert M; Mayer CT; Huehn J; Ponimaskin E; Abraham WR; Müller R; Lochner M; Sparwasser T
    Nat Med; 2014 Nov; 20(11):1327-33. PubMed ID: 25282359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Stem Cell Protects Injured Renal Tubular Epithelial Cells by Regulating mTOR-Mediated Th17/Treg Axis.
    Luo Y; Guo J; Zhang P; Cheuk YC; Jiang Y; Wang J; Xu S; Rong R
    Front Immunol; 2021; 12():684197. PubMed ID: 34122446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugars and fat - A healthy way to generate functional regulatory T cells.
    Gabriel SS; Kallies A
    Eur J Immunol; 2016 Dec; 46(12):2705-2709. PubMed ID: 27918097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Regulation of Human Treg and Th17 Cells by Fatty Acid Synthesis and Glycolysis.
    Cluxton D; Petrasca A; Moran B; Fletcher JM
    Front Immunol; 2019; 10():115. PubMed ID: 30778354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus.
    Shan J; Jin H; Xu Y
    Front Immunol; 2020; 11():1027. PubMed ID: 32528480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR Signaling pathway as a master regulator of memory CD8
    Rostamzadeh D; Yousefi M; Haghshenas MR; Ahmadi M; Dolati S; Babaloo Z
    J Cell Physiol; 2019 Aug; 234(8):12353-12368. PubMed ID: 30710341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamine metabolism in Th17/Treg cell fate: applications in Th17 cell-associated diseases.
    Yang G; Xia Y; Ren W
    Sci China Life Sci; 2021 Feb; 64(2):221-233. PubMed ID: 32671630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinase ITK controls a Ca
    Anannya O; Huang W; August A
    Sci Signal; 2024 Jul; 17(846):eadh2381. PubMed ID: 39042726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal Regulation of Glycolysis-Driven Th17 Pathogenicity and Regulatory T Cell Stability by Cdc42.
    Kalim KW; Yang JQ; Li Y; Meng Y; Zheng Y; Guo F
    J Immunol; 2018 Apr; 200(7):2313-2326. PubMed ID: 29440353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice.
    Yao J; Wei C; Wang JY; Zhang R; Li YX; Wang LS
    World J Gastroenterol; 2015 Jun; 21(21):6572-81. PubMed ID: 26074695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs.
    Park MJ; Lee SY; Moon SJ; Son HJ; Lee SH; Kim EK; Byun JK; Shin DY; Park SH; Yang CW; Cho ML
    Transl Res; 2016 Jul; 173():115-130. PubMed ID: 27126953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation.
    Kalim KW; Basler M; Kirk CJ; Groettrup M
    J Immunol; 2012 Oct; 189(8):4182-93. PubMed ID: 22984077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR promotes an inflammatory response through the HIF1 signaling pathway in ulcerative colitis.
    Wang Y; Li M; Zha A
    Int Immunopharmacol; 2024 Jun; 134():112217. PubMed ID: 38718658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis.
    Liu H; Yao S; Dann SM; Qin H; Elson CO; Cong Y
    Eur J Immunol; 2013 Jul; 43(7):1716-26. PubMed ID: 23620016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.